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Background: Individuals with diabetes may develop cardiac autonomic dysfunction that may be evaluated by
heart rate variability (HRV). The aim was evaluated heart rate variability (HRV) of individuals with type 2 diabetes,
without cardiovascular autonomic neuropathy (CAN), in response to active postural maneuver by means of
nonlinear analysis (symbolic analysis, Shannon and conditional entropy) and correlate HRV parameters between
them, glycated hemoglobin and diabetes duration.
Methods: Nineteen men with type 2 diabetes without CAN (T2D) and nineteen healthy men (CG), age-range from
40 to 60 years were studied. We assessed HRV in supine and orthostatic position using symbolic analysis (0V%, 1V%,
2LV% and 2UV%), Shannon and conditional entropy (SE and NCI).
Results: In supine position T2D presented higher sympathetic modulation (0V%) than CG. However, there was not
any difference between groups for indexes of complexity (SE and NCI). Furthermore, T2D presented a preserved
response of cardiac autonomic modulation after active postural maneuver.
Conclusions: The present study showed that individuals with type 2 diabetes without CAN presented higher cardiac
sympathetic modulation. However, the complexity of HRV was not influenced by imbalance of the autonomic
modulation in individuals with type 2 diabetes. In addition, the response of autonomic nervous system in the heart
remains preserved after active postural maneuver in individuals with type 2 diabetes, possibly due to the lack of CAN in
this group.
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Type 2 diabetes is a metabolic disorder of multiple eti-
ologies characterized by hyperglycemia, insulin resist-
ance and a variable degree of insulin secretory deficiency
[1,2]. It is considered as a cardiovascular risk factor, as
individuals with diabetes have double the risk of devel-
oping acute myocardial infarction and stroke than those
who do not have it [3].
Individuals with diabetes may develop autonomic dys-
function related to the cardiovascular system, known as
cardiovascular autonomic neuropathy (CAN). This dys-
function occurs where there are lesions in the peripheral
autonomic fibers [4].* Correspondence: mcatai@ufscar.br
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article, unless otherwise stated.Cardiac autonomic dysfunction, characterized by alter-
ations in the modulation the cardiac vagal, or sympa-
thetic efferents, or in both, may be evaluated by heart
rate variability (HRV) [5], which is a simple, non invasive
measurement [6,7] and is considered a predictor of cardio-
vascular morbidity and mortality [8]. It can be evaluated
under conditions of rest [9,10], and during provocative
tests such as physical exercise [11,12], the tilt test [13,14]
and active postural maneuver [15,16].
Postural change promotes stimulus of the autonomic
nervous system (ANS) in the heart by inducing an increase
in sympathetic modulation during the tilt test [14,17] and
with active postural maneuver [16,18]. In addition, active
postural maneuver is a simpler evaluation when compared
with the tilt test, and it is, also, a low cost method that can
be performed at the bedside [16,18].Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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methods. Javorka et al. [9] developed study involving non-
linear analysis to assess the complexity of HRV (Shannon
and conditional entropy) of young patients with type 1
diabetes. They observed reduction in the complexity of
HRV for this population. In addition, Javorka et al. [9] per-
formed symbolic analysis and observed reduction index
2LV% (index that reflects parasympathetic and sympa-
thetic modulation with parasympathetic predominance).
The authors attributed these results to vagal dysfunction
[9]. However, there is a scarcity of studies that evaluate
the HRV by nonlinear analysis in patients with type 2
diabetes.
Therefore, the primary objective was to evaluate the
HRV of individuals with type 2 diabetes, without cardio-
vascular autonomic neuropathy (CAN), in response to
active postural maneuver from the supine to orthostatic
position, by means of nonlinear analysis (symbolic ana-
lysis, Shannon and conditional entropy). Our secondary
aim was to correlate the duration of diabetes and gly-
cated hemoglobin (HbA1c) with used HRV indexes.Methods
Subjects
Thirty eight male volunteers, age-range from 40 to 65
years were evaluated. They were divided into two groups:
one of subjects with type 2 diabetes in accordance with
the recommendations of the American Diabetes Associ-
ation [19] (T2D; n = 19) and the other group of control
subjects (Control Group – CG; n = 19).
Volunteers were selected in accordance with the follow-
ing criteria: sedentary, with aerobic functional classified as:
very weak, weak, or reasonable according to the American
Heart Association [20], non-smokers, non-drinkers and
people without any kind of lung disease or systemic in-
flammatory disease. The exclusion criteria were as follows:
diagnostic CAN (verified by clinical evaluation by an endo-
crinologist, slow deep breathing autonomic testing –
according to O’Brien et al. [21]; tachycardia at rest – heart
rate > 100 bpm; orthostatic hypotension in reaction to ac-
tive postural change – systolic blood pressure > 30 mmHg)
[21], myocardial ischemia and/or cardiovascular patholo-
gies on clinical examinations and clinical ergometric test
conducted by a Physician, disease that incapacity the sub-
ject to remain in the orthostatic position actively, or walk
and/or pedal the bicycle, and a body mass index (BMI)
greater than 29.99 Kg/m2 for the CG.
The present study was approved by the Ethics Commit-
tee on Research in Human Beings of the Federal Univer-
sity of São Carlos (Protocol N. 093/2011). All the subjects
who participated in the study were informed about the
experimental procedures and signed a Formal Consent
Agreement.Experimental procedure
The experimental procedures were performed in the
Cardiovascular Physiotherapy Laboratory at the Federal
University of São Carlos and only blood collection was
performed at the Clinical Analysis Laboratory. The study
was always conducted in the morning period, consider-
ing the effects of the circadian rhythm. The experiments
were carried out in a climate-controlled room (22-23°C)
with a relative air humidity of 50-60%.
The protocols were performed in two days with a dif-
ference of one week between them: 1) blood collection,
body composition evaluation, autonomic testing and car-
diopulmonary exercise testing; 2) instantaneous R–R inter-
vals (RRi) were recorded for HRV analysis. The volunteers
were instructed not to practice moderate or heavy exercise,
and not ingest food and/or stimulating or alcoholic bever-
ages within 24 hours before the evaluations, and to fast for
12 hours on the day of blood collection.
Laboratory exams
The volunteers were subjected to venous blood collec-
tion for lipid profile, C-reactive protein (CRP), glycated
hemoglobin (HbA1c) analysis, and afterwards the mean
estimated glycemia was calculated. For these analyses
ADVIA 1800 Chemistry System (Siemens, Tarrytown, NY,
USA) was used.
Body composition
The body composition monitor Tanita Ironman (Tanita
Corporation of America Inc, Illinois, USA) was used to
evaluate the total body fat percentage of the volunteers.
Cardiopulmonary exercise testing
The symptom-limited cardiopulmonary exercise testing
[22], was performed to confirm that subjects were classified
at the same functional class [20]. The maximum volume of
O2 consumption (VO2 peak) was determined during an in-
cremental cycle ergometer exercise, with increments calcu-
lated by the Wasserman formula [23], using a metabolic
analyzer (CPX/D, MedGraphics, St. Paul, MN, USA).
Heart rate variability (HRV)
The HRV was obtained by the cardiofrequencymeter
Polar® RS800CX™ (Polar Electro Oy, Kempele, Finland).
This system captures the R wave of the ECG, with a
sampling frequency of 500 Hz, thus calculating the HR
instantly and storing the RRi in the same way it is done
with the Polar® S810i cardiofrequencymeter described by
Vanderlei et al. [24].
The volunteers were instructed to lie down in the su-
pine position, not to move and/or talk during RRi cap-
ture. Before starting the volunteers remained at rest in
the supine position for 10 min, in order to stabilize the
cardiovascular variables. The RRi records the protocol
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Then the systemic blood pressure was measured. Next, the
volunteer was instructed to perform active postural change
to the orthostatic position, and the system blood pressure
was measured again. Finally, the RRi was recorded for
the last time in the orthostatic position for the next
10 minutes.
The series length N was fixed at 256 beats in each pos-
ition. The sequence of RRi with the greatest stability in
the central region of the tachogram was selected for each
volunteer in both positions. The same sequence selected
was used to perform all the analyses.
Symbolic dynamics
Shannon entropy
The Shannon Entropy is obtained by quantizing of the
RRi series into six levels ranging from 0 to 5, that means
that each heartbeat corresponds to a symbol according
to the level of the heartbeat. Therefore, they are orga-
nized into patterns with 3 symbols. The shape and distri-
bution of these patterns was calculated with Shannon
entropy (SE). The SE is large if its distribution is flat (all
patterns are identically distributed and the series carries
the maximum amount of information). However, if there
is a subset of more probable patterns, while others are
missing or infrequent (e.g., in a Gaussian distribution),
SE will be small [25].
Symbolic analysis
Symbolic analysis was carried out by grouping the pat-
terns with 3 symbols into four families as follows: (a) no
variation (0V: all the symbols are equal, i.e. 2,2,2 or
4,4,4); (b) one variation (1V: 2 consecutive symbols are
equal and the remaining symbol is different, i.e. 4,2,2 or
4,4,3); (c) two like variations (2LV: the 3 symbols form
an ascending or descending ramp, i.e. 5,4,2 or 1,3,4); and
(d) two unlike variations (2UV: the three symbols form a
peak or a valley, i.e. 4,1,2 or 3,5,3). The rate of occur-
rence for each pattern is defined as 0V%, 1V%, 2LV%,
and 2UV% [26]. It has been observed that 0V% reflects
only sympathetic modulation, 1V% reflects sympathetic
and parasympathetic modulation, 2LV% reflects sympa-
thetic and parasympathetic modulation with vagal predom-
inance and 2UV% reflects, exclusively, vagal modulation
[14,26].
Conditional entropy
According to Porta et al. [26], conditional entropy (CE)
measures the amount of information carried by the most
recent sample of patterns that cannot be derived from a
sequence of values of length of past patterns. CE is
assessed with the complexity index (CI). We normalized
this index with the Shannon entropy of the RRi to obtain
a normalized complexity index (NCI) that expressescomplexity in terms of dimensionless units. This index
ranges from 0 (null information) to 1 (maximum informa-
tion). The larger both indexes are, the greater the com-
plexity, the lower the regularity.
Statistical analysis
The Shapiro-Wilk normality test was used to identify the
distribution of data. Non-normal distribution data were
transformed by the log10 and they became normal. After-
wards two-way ANOVA was used to analyze variables
considering the effect of the group, effect of position and
interaction among them. The Holm-Sidak post hoc was
used to show the differences. The correlation between dur-
ation of diabetes and glycated hemoglobin (HbA1c) with
HRV indexes were determined by Pearson. P value < 0.05
was considered statistically significant. The data were pre-
sented as mean ± SD. Sigma Plot software for Windows
version 11.00 was used for data analysis.
Results
The data shown in Table 1 were presented to characterize
the studied sample. There was significant difference be-
tween the groups for HbA1c and estimated mean glycemia,
an expected result, since these exams are generally shown
to be altered in individuals with diabetes (Table 1) [27].
T2D group was evaluated by an endocrinologist and
was subjected to tests that assess autonomic nervous
system (slow deep breathing autonomic testing, tachy-
cardia at rest and orthostatic hypotension in reaction to
active postural). All subjects had normal values for auto-
nomic testing and in clinical evaluation all subjects de-
nied dizziness or sweating with postural maneuver, and
they did not report sexual dysfunction, sensory loss of
vibration, pressure, pain and temperature perception in
the lower limbs, therefore all subjects were diagnosed
without CAN.
T2D medication to control diabetes (hypoglycemic drugs
and/or insulin). In addition, some individuals with diabetes
used too antihypertensive, hypolipidemic drugs (Table 1).
Both groups showed an increase in HR and reduction
in mean RRi in active postural maneuver. To variance of
RRi the groups were different regardless of posture, with
T2D presenting lower values than CG in both positions
(Table 2).
With respect to Shannon entropy, there were not group
and position effect. Whereas the normalized complexity
index (NCI) presented position effect (p < 0.05), because
both groups presented a reduction in their values in the
transition from the supine to orthostatic position (Figure 1).
Regarding the symbolic analysis indexes, there was an
effect of both groups and position on 0V%, 1V% and
2LV%. The active postural maneuver led to an increase on
0V% and a decrease on 1V% and 2LV% for both groups.
In addition, T2D presented higher values for 0V% and
Table 1 Characteristics of evaluated groups
Characteristics T2D CG P-value
Age (years) 50.53 ± 6.96 50.26 ± 7.96 0.345
Body mass (Kg) 86.64 ± 13.86 80.24 ± 9.38 0.057
Height (m) 1.74 ± 0.09 1.75 ± 0.08 0.823
BMI (Kg/m2) 28.26 ± 4.13 26.21 ± 1.77 0.062
Percentage of total body fat 24.94 ± 6.20 23.38 ± 3.61 0.384
VO2 peak (ml/min) 1672.05 ± 345.01 1850.89 ± 238.09 0.070
Time of diabetes (years) 11.13 ± 6.41 - -
Laboratory Exams
PCR (mg/dL) 1.12 ± 1.48 0.69 ± 0.66 0.874
HbA1c (%) 8.54 ± 2.15 5.85 ± 0.30 <0.001*
HbA1c (mmol/mol) 69.80 ± 23.55 40.44 ± 3.26 <0.001*
Estimated mean glycemia (mg/dL) 197.79 ± 61.91 119.47 ± 9.95 <0.001*
Total cholesterol (mg/dL) 193.79 ± 28.61 198.21 ± 39.33 0.635
HDL-cholesterol (mg/dL) 45.37 ± 10.32 46.79 ± 11.02 0.573
LDL-cholesterol (mg/dL) 113.53 ± 32.12 119.26 ± 30.62 0.253
VLDL-cholesterol (mg/dL) 33.84 ± 18.49 31.05 ± 16.11 0.452
Triglycerides (mg/dL) 170.47 ± 92.57 156.37 ± 80.06 0.093
Risk factors
Hypertension 2 (10.53%) - -
Obesity 5 (26.31%) - -
Dyslipidemia 7 (36.84%) 9 (47.37%) -
Medications
Oral hypoglycemic drugs 8 (42.11%) - -
Insulin 4 (21.05%) - -
Oral hypoglycemic drugs + insulin 4 (21.05%)
Anti-hypertensive drugs 5 (26.31%) - -
ACE Inhibitor 1 (5.26%) - -
- Calcium channel blocker (amlodipina) 1 (5.26%) - -
- Angiotensin II receptor antagonist 2 (10.53%) - -
- Hydrochlorothiazide 1 (5.26%) - -
- Clonidine 1 (5.26%) - -
- Hypolipidemic drug 2 (10.53%) 3 (15.79%)
Deep breathing testing
E/I 1.27 ± 0.20 1.29 ± 0.16 0.352
ΔIE 18.53 ± 14.94 16.73 ± 8.82 0.494
The data are presented in mean ± standard deviation. T2D = group with type 2 diabetes; CG = Control Group; BMI = body mass index; VO2 peak = oxygen
consumption at peak of physical effort; PCR = C-reactive protein; HbA1c = glycated hemoglobin.*p < 0.05.
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compared with CG. Whereas the index 2UV% was af-
fected only by position effect, which shows that regardless
of the group, there is alteration of this index with active
postural change (Figure 1).
Table 3 show that there was not a correlation [28] be-
tween parameters of HRV and HbA1c, duration of dia-
betes and indexes of slow deep breathing in T2D.Discussion
The main finding of the present study is that individuals
with type 2 diabetes without diagnosed of CAN presented
higher sympathetic modulation than CG, but the imbal-
ance of the autonomic modulation did not influence the
complexity of HRV yet. In addition, the response of ANS
in the heart remains preserved after active postural man-
euver in individuals with type 2 diabetes without CAN.
Table 2 Systolic and diastolic blood pressure (mmHg), heart rate (bpm), R-R interval (RRi) and heart rate variance (VAR)
Variables T2D CG P-value
Supine Orthostatic Supine Orthostatic Group Position Interaction
Mean ± SD CI Mean ± SD CI Mean ± SD CI Mean ± SD CI
SBP (mmHg) 135 ± 16.4 (126.2–143.8) 128.8 ± 16.0 (120.2–137.3) 129.0 ± 9 (124.3–133.9) 122.2 ± 11.00 (116.4–128.0) 0.068 0.056 0.926
DBP (mmHg) 86.3 ± 12.0 (79.8–92.7) 82.8 ± 11.0 (77–88.7) 82.2 ± 8 (78–86.4) 76.4 ± 20.3 (65.6–87.3) 0.131 0.182 0.735
HR (bpm) 72.8 ± 8.7 (68.6–77.0) 83.3 ±11.5 (77.7–88.8) 67.3 ± 10.4 (62.3–72.3) 81.1 ± 13.5 (74.6–87.6) 0.140 <0.001* 0.517
RRi mean (ms) 836.4 ± 106.1 (785.3–887.6) 734.4 ± 107.5 (682.5–786.2) 911.3 ± 135.3 (846.1–976.6) 760.1 ± 131.7 (696.7–823.6) 0.074 <0.001* 0.378
VAR (ms2) 485.4 ± 304.3 (338.8–632.1) 327.0 ± 197.1 (232.0–422.0) 1010.6 ± 745 (651.6–1369.7) 763.9 ± 623.6 (463.3–1064.4) <0.001* 0.187 0.885
The data are presented in mean ± standard deviation (Mean ± SD) and confidence intervals of mean (CI). T2D = group type 2 diabetes; CG = Control Group; SBP = systolic blood pressure; DBP = diastolic blood pressure;






















Figure 1 Symbolic dynamics of HRV for individuals with type 2 diabetes (T2D) and and control group (CG). The symbol *indicates p <0.05 and
† indicates p <0.001. A: 0V% index; B: 1V% index; C: 2LV% index; D: 2UV% index; E: SE = Shannon entropy; F: NCI = normalized complexity index.
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In the present study we observed that T2D presented
an increase of sympathetic modulation, characterized by
an increase of index 0V% regardless of the position
adopted. In addition, T2D presented decrease of 2LV% that
reflects sympathetic and parasympathetic modulation, withparasympathetic predominance. There was not difference
between groups for 2UV% that reflects exclusively vagal
modulation. Javorka et al. [9] also found a reduction in 2LV
% with statistically significant difference when compared
youngsters with type 1 diabetes with the control group in
the supine position.
Table 3 Correlation between the parameters of heart rate variability and glycated hemoglobin, duration of diabetes
and indexes of slow deep breathing in T2D
0V% 1V% 2LV% 2UV% SE NCI
Supine
HbA1c (%) r = −0.03 r = −0.07 r = −0.10 r = 0.20 r = 0.01 r = − 0.03
p = 0.91 p = −0.78 p = 0.67 p = 0.40 p = 0.94 p = 0.88
Duration of Diabetes r = 0.02 r = 0.17 r = 0.30 r = −0.25 r = 0.12 r = −0.19
p = 0.93 p = 0.50 p = 0.22 p = 0.29 p = 0.63 p = 0.43
E/I r = −0.24 r = 0.35 r = 0.13 r = 0.18 r = 0.16 r = 0.31
p = 0.35 p = 0.18 p = 0.63 p = 0.50 p = 0.55 p = 0.23
ΔIE r = 0.08 r = 0.256 r = − 0.19 r = − 0.03 r = − 0.24 r = 0.21
p = 0.78 p = 0.34 p = 0.50 p = 0.93 p = 0.37 p = 0.44
Orthostatic
HbA1c (%) r = −0.13 r = −0.06 r = −0.08 r = −0.08 r = −0.01 r = 0.02
p = 0.50 p = 0.60 p = 0.80 p = 0.71 p = 0.94 p = 0.91
Duration of Diabetes r = 0.17 r = −0.01 r = −0.19 r = −0.07 r = −0.10 r = −0.35
p = 0.50 p = 0.96 p = 0.42 p = 0.76 p = 0.67 p = 0.14
E/I r = −0.16 r = 0.22 r = − 0.10 r = 0.13 r = 0.01 r = 0.14
p = 0.56 p = 0.42 p = 0.71 p = 0.63 p = 0.97 p = 0.61
ΔIE r = 0.23 r = − 0.274 r = − 0.33 r = 0.14 r = − 0.34 r = 0.18
p = 0.39 p = 0.30 p = 0.22 p = 0.62 p = 0.20 p = 0.52
T2D = group type 2 diabetes; Symbolic analysis indexes (0V%, 1V%, 2LV% and 2UV%); SE = Shannon Entropy; CI = complexity Index; NCI = normalized complexity
index; E/I = relationship between expiration and inspiration; ΔIE = heart rate during inspiration - heart rate during expiration. There were no significant correlations.
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in spite of its position. Probably, this result is due to the
dysfunction of the ANS because this index reflects both
sympathetic and parasympathetic modulation, with sym-
pathetic predominance [25].
In the individuals with type 2 diabetes who develop
CAN, the first to present lesion is the vagal nerve, and
this allows a greater action of the sympathetic system on
the heart [29]. However, our subjects did not present
CAN, perhaps, they did not present irreversible lesion in
vagal nerve yet, because there was not any difference be-
tween T2D and CG for 2UV%, but T2D presented a
autonomic dysfunction reflected in a decrease of 2LV%
and an increase of 0V%. Javorka et al. [30] suggested that
the autonomic dysfunction in initial phases may be a
consequence of functional changes of the neurons which
can be reversible, for example mentioned by the authors,
endoneural edema caused by hyperglycemia.
In the study of Khandoker et al. [31], it was observed that
patients with type 2 diabetes with CAN presented lower
complexity evaluated by sample entropy in comparison
with the group with type 2 diabetes without neuropathy.
Javorka et al. [30] did not find difference between healthy
subjects and subjects with type 1 diabetes for complexity of
HRV using also sample entropy. In another study, using
NCI, the authors observed a reduction of complexity in
subjects with type 1 diabetes compared with healthysubjects [9]. In our study, we did not find difference be-
tween subjects with type 2 diabetes and healthy subjects for
complexity of HRV evaluated by Shannon entropy (SE)
(that quantifies the degrees of complexity of the distribution
of temporal sequence patterns of HRV that may be absent
or not very frequent, determining lower complexity) and
conditional entropy (NCI) (form in which these patterns
are related, that is to say, the sequence in which they are or-
ganized). Nevertheless, it is interesting to note that in the
present study, the complexity of HRV was not affected by
the presence of diabetes, this is possibly due to the absence
of cardiac autonomic neuropathy installed, even with
known autonomic imbalance.
Effect of postural change
Active postural maneuver is an important method to evalu-
ate the HRV because it stimulates the ANS, and moreover
it is a simpler and cheaper than tilt test [16,18]. In the
present study both groups presented an increased in the
heart rate (HR) and a reduction in the mean of RRi with ac-
tive postural maneuver. A similar result was observed by
Perseguini et al. [16] with postural change in healthy men.
Indexes of symbolic analysis showed effect of postural
maneuver in modulation of ANS in heart for both
groups. There was increasing 0V% and reduced 1V%,
2LV% and 2UV%. Similar results were found in other
studies [14,25,32]. This response may be attributed to
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elevation in HR, due to cardiac autonomic regulation
(inhibition of vagal and stimulation of sympathetic modu-
lation), which is mediated by the adjustments of the cardio-
pulmonary and arterial baroreceptors with postural change
from the supine to the orthostatic position [33]. These re-
sults showed that both groups responded to maneuver, i.e.,
the autonomic modulation of T2D without CAN remains
able to properly respond to active postural maneuver.
As regards Shannon entropy analysis, both groups did
not present a reduction in complexity with postural change.
These findings were not in agreement with those of the
study of Porta et al. [25], who evaluated healthy subjects
and observed a reduction in Shannon entropy during the
tilt test, and attributed this response to the increase in the
percentage of absent patterns. This difference may be due
to postural change have been active and not through a pos-
tural table, ie the active postural maneuvers may have less
influence in ANS compared to tilt test.
Conditional entropy is a measure of complexity of the dy-
namics between a pattern and the next one (regularity), so
that the higher the regularity, the lower the value of condi-
tional entropy index (NCI) [25]. Porta et al. [34], studying
healthy young subjects, observed an increase in the regular-
ity of the temporal sequence with the tilt test, and attrib-
uted this finding to the increase in sympathetic modulation
and reduction in parasympathetic modulation, which were
capable of reducing the complexity of the RRi. In the
present study NCI also presented reduction with active
postural change in both groups, which shows a greater re-
gularity in the temporal sequence with orthostatic change,
due to sympathetic predominance (0V%) and reduction in
parasympathetic modulation (2UV%) in response to the
active postural maneuver. These results show that there is
a reduction in complexity in the presence of an increase inFigure 2 Flow diagram indicating sampling loss in the study.sympathetic modulation and decrease in vagal modulation.
This data is in accordance with Porta et al. [26]. Therefore,
both groups had reduction in complexity (NCI) with active
postural change. Thus, these groups presented a preserved
response of cardiac autonomic modulation after active pos-
tural maneuver, i.e., diabetes did not influence the results of
complexity evaluated with active postural maneuvers. We
attributed this result to the absence of CAN, since the sub-
jects with diabetes did not have neuropathy installed.
Glycemic control and duration of diabetes
The injury mechanisms of sympathetic and parasympa-
thetic branches are not completely understood. Several
hypotheses are considered in the process of pathogenesis
of CAN. The hyperglycemia is considered the permissive
pathogenetic factor [35] because it activates various bio-
chemical pathway leading development and progression
of CAN [5,36,37]. Therefore, due to this hypothesis, gly-
cemic control is considered the main approach in the
treatment of CAN [35]. Furthermore, the duration of
the disease has been studied as a factor involved in car-
diovascular autonomic neuropathy [38].
Previous studies with diabetes type 1 confirmed the cor-
relation between HRV parameters and HbA1c and duration
of diabetes [39,40], but there are others studies that did not
confirm these association [30,38]. Study with diabetes type
1 and 2 found no association between HRV and HbA1c
[38]. While Nolan et al. [41] found a negative association of
vagal modulation with the duration of type 2 diabetes in
men. In the present study there was not any association be-
tween HRV and HbA1c and duration of type 2 diabetes.
Clinical implications
The use of the symbolic analysis in the periodic evalu-
ation of subjects with type 2 diabetes may help in the
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CAN, which allows interventions and guidance to be pro-
vided, before greater complications become established [5].
Subjects with type 2 diabetes without cardiovascular
autonomic neuropathy installed may have cardiac auto-
nomic dysfunction. It can be observed by the fact that
T2D began with increased value of the index related to
the sympathetic autonomic system (0V%) and decreased
value of the 2LV% that reflects sympathetic and para-
sympathetic with predominance vagal modulation. The
evaluation of HRV before and after active postural man-
euver is a simple and low cost test that can be per-
formed at the bedside [16]. Furthermore, this test may
be used in the clinical evaluation because it is a stimulus
for ANS [16,18]. However, in present investigation, it was
not possible to observe differences between groups with
this test. This, possibly, occurred due to lack of neur-
opathy in TD2 and both groups present ANS response
with active postural maneuvers.
Study limitations
The number of subjects studied in each group is small
due to the sample loss during the study (Figure 2). How-
ever, it is noteworthy that the number of subjects was
sufficient to detect some important differences in HRV
as described above. Furthermore, we did not analyze the
fasting glucose and insulin (laboratory tests that are com-
mon in the literature), however there are studies that did
not show correlation between these laboratory tests and
HRV [42,43].
Conclusions
The present study showed that individuals with type 2 dia-
betes without CAN presented higher sympathetic modula-
tion. However, the complexity of HRV was not influenced
by imbalance of the autonomic modulation in individuals
with type 2 diabetes. In addition, the response of ANS in
the heart remains preserved after active postural maneu-
ver in individuals with type 2 diabetes, possibly due to lack
of CAN in this group.
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